Follow The Filings

VSTM Verastem

Verastem earnings company data as of 12:01 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by VSTM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VSTM insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $1.1M sold by 6 insiders under 10b5-1 plans
  1. Dan Paterson CEO
    Planned sale
    $353K 44,121 shares at $8.00 6.3% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  2. Daniel Calkins CFO
    Planned sale
    $21K 2,566 shares at $8.00 2% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  3. Daniel Calkins CFO
    Planned sale
    $424 55 shares at $7.70 <0.1% of stake
    Traded Sep 21 Filed Sep 23
    ↗
  4. Dan Paterson CEO
    Planned sale
    $7,565 1,302 shares at $5.81 0.2% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  5. Dan Paterson CEO
    Planned sale
    $87K 20,871 shares at $4.18 3.4% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  6. Daniel Calkins CFO
    Planned sale
    $17K 4,089 shares at $4.18 3.4% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  7. Dan Paterson CEO
    Planned sale
    $4,691 806 shares at $5.82 0.1% of stake
    Traded May 4 Filed May 6
    ↗
  8. Dan Paterson CEO
    Planned sale
    $6,489 970 shares at $6.69 0.2% of stake
    Traded Feb 4 Filed Feb 5
    ↗
  9. Dan Paterson CEO
    Planned sale
    $74K 10,321 shares at $7.16 2.5% of stake
    Traded Jan 12 Filed Jan 14
    ↗
  10. Daniel Calkins CFO
    Planned sale
    $36K 5,039 shares at $7.16 4.6% of stake
    Traded Jan 12 Filed Jan 14
    ↗
  11. Daniel Calkins CFO
    Planned sale
    $629 80 shares at $7.86 0.1% of stake
    Traded Dec 24, 2025 Filed Dec 29, 2025
    ↗
  12. Brian M Stuglik Director
    Planned sale
    $5,411 592 shares at $9.14 0.6% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  13. Dan Paterson CEO
    Planned sale
    $3,592 393 shares at $9.14 0.1% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  14. Robert E. Gagnon Director
    Planned sale
    $2,587 283 shares at $9.14 0.7% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  15. Dan Paterson CEO
    Planned sale
    $40K 4,000 shares at $10.04 1% of stake
    Traded Dec 10–11 Filed Dec 12, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,5.02,7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.03,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.